{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:36:45Z","timestamp":1778045805789,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK069350"],"award-info":[{"award-number":["DK069350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 32333"],"award-info":[{"award-number":["DK 32333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK074457"],"award-info":[{"award-number":["DK074457"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12020-016-1101-8","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T05:46:55Z","timestamp":1476769615000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism"],"prefix":"10.1007","volume":"55","author":[{"given":"Cristiana","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie E.","family":"Cusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishaela R.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Hans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"1101_CR1","first-page":"801","volume":"34","author":"BC Silva","year":"2011","unstructured":"B.C. Silva, A.G. Costa, N.E. Cusano, S. Kousteni, J.P. Bilezikian, Catabolic and anabolic actions of parathyroid hormone on the skeleton. J. Endocrinol. Invest. 34, 801\u2013810 (2011)","journal-title":"J. Endocrinol. Invest."},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"SJ Silverberg","year":"1989","unstructured":"S.J. Silverberg, E. Shane, L. de la Cruz, D.W. Dempster, F. Feldman, D. Seldin, T.P. Jacobs, E.S. Siris, M. Cafferty, M.V. Parisien, R. Lindsay, T.L. Clemens, J.P. Bilezikian, Skeletal disease in primary hyperparathyroidism. J. Bone Miner. Res. 4, 283\u2013291 (1989)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","volume":"41","author":"DW Dempster","year":"2007","unstructured":"D.W. Dempster, R. Muller, H. Zhou, T. Kohler, E. Shane, M. Parisien, S.J. Silverberg, J.P. Bilezikian, Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 41, 19\u201324 (2007)","journal-title":"Bone"},{"key":"1101_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","volume":"18","author":"BL Langdahl","year":"1996","unstructured":"B.L. Langdahl, L. Mortensen, A. Vesterby, E.F. Eriksen, P. Charles, Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone. 18, 103\u2013108 (1996)","journal-title":"Bone."},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"M.R. Rubin, D.W. Dempster, H. Zhou, E. Shane, T. Nickolas, J. Sliney Jr., S.J. Silverberg, J.P. Bilezikian, Dynamic and structural properties of the skeleton in hypoparathyroidism. J. Bone Miner. Res. 23, 2018\u20132024 (2008)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR6","doi-asserted-by":"publisher","unstructured":"N.E. Cusano, K.K. Nishiyama, C. Zhang, M.R. Rubin, S. Boutroy, D.J. McMahon, X.E. Guo, J.P. Bilezikian, Non-invasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism. J. Bone Miner. Res. (2015). doi: 10.1002\/jbmr.2609","DOI":"10.1002\/jbmr.2609"},{"key":"1101_CR7","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"J.P. Bilezikian, A. Khan, J.T. Potts Jr., M.L. Brandi, B.L. Clarke, D. Shoback, H. J\u00fcppner, P. D\u2019Amour, J. Fox, L. Rejnmark, L. Mosekilde, M.R. Rubin, D. Dempster, R. Gafni, M.T. Collins, J. Sliney, J. Sanders, Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 26, 2317\u20132337 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"S. Khosla, L.J. Melton 3rd, R.A. Wermers, C.S. Crowson, W. O\u2019Fallon, B. Riggs, Primary hyperparathyroidism and the risk of fracture: a population-based study. J. Bone Miner. Res. 14, 1700\u20131707 (1999)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"E. Vignali, G. Viccica, D. Diacinti, F. Cetani, L. Cianferotti, E. Ambrogini et al., Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 2306\u20132312 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","volume":"27","author":"P Vestergaard","year":"2003","unstructured":"P. Vestergaard, L. Mosekilde, Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J. Surg. 27, 343\u2013349 (2003)","journal-title":"World J. Surg."},{"key":"1101_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","volume":"73","author":"N Yu","year":"2010","unstructured":"N. Yu, P.T. Donnan, R.W. Flynn, M.J. Murphy, D. Smith, A. Rudman, G.P. Leese, Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin. Endocrinol. (Oxf.) 73, 30\u201334 (2010)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1101_CR12","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00198-013-2316-7","volume":"24","author":"JP Roux","year":"2013","unstructured":"J.P. Roux, J. Wegrzyn, S. Boutroy, M.L. Bouxsein, D. Hans, R. Chapurlat, The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study. Osteoporos. Int. 24, 2455\u20132460 (2013)","journal-title":"Osteoporos. Int."},{"key":"1101_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bone.2015.06.007","volume":"79","author":"C Muschitz","year":"2015","unstructured":"C. Muschitz, R. Kocijan, J. Haschka, D. Pahr, A. Kaider, P. Pietschmann, D. Hans, G.K. Muschitz, A. Fahrleitner-Pammer, H. Resch, BS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone 79, 259\u2013266 (2015)","journal-title":"Bone"},{"key":"1101_CR14","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/jbmr.98","volume":"25","author":"S Hansen","year":"2010","unstructured":"S. Hansen, J.E. Beck Jensen, L. Rasmussen, E.M. Hauge, K. Brixen, Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J. Bone Miner. Res. 25, 1941\u20131947 (2010)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR15","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1210\/jc.2012-4255","volume":"98","author":"BC Silva","year":"2013","unstructured":"B.C. Silva, S. Boutroy, C. Zhang, D.J. McMahon, B. Zhou, J. Wang, J. Udesky, S. Cremers, M. Sarquis, X.D. Guo, D. Hans, J.P. Bilezikian, Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 98, 1963\u20131970 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jbmr.1841","volume":"28","author":"EM Stein","year":"2013","unstructured":"E.M. Stein, B.C. Silva, S. Boutroy, B. Zhou, J. Wang, J. Udesky, C. Zhang, D.J. McMahon, M. Romano, E. Dworakowski, A.G. Costa, N. Cusano, D. Irani, S. Cremers, E. Shane, X.E. Guo, J.P. Bilezikian, Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J. Bone Miner. Res. 28, 1029\u20131040 (2013)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341, 1249\u20131255 (1999)","journal-title":"N. Engl. J. Med."},{"key":"1101_CR18","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"M.R. Rubin, J.P. Bilezikian, D.J. McMahon, T. Jacobs, E. Shane, E. Siris, J. Udesky, S.J. Silverberg, The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J. Clin. Endocrinol. Metab. 93, 3462\u20133470 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR19","first-page":"729","volume":"80","author":"SJ Silverberg","year":"1995","unstructured":"S.J. Silverberg, F. Gartenberg, T.P. Jacobs, E. Shane, E. Siris, R.B. Staron, D.J. McMahon, J.P. Bilezikian, Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 80, 729\u2013734 (1995)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-13-0305","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"C. Eller-Vainicher, M. Filopanti, S. Palmieri, F.M. Ulivieri, V. Morelli, V.V. Zhukouskaya, E. Cairoli, R. Pino, A. Naccarato, U. Verga, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 169, 155\u2013162 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1101_CR21","first-page":"2504","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J. Clin. Endocrinol. Metab. 29, 2504\u20132510 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR22","doi-asserted-by":"crossref","unstructured":"M.L. Mendon\u00e7a, F.A. Pereira, M.H. Nogueira-Barbosa, L.M. Monsignore, S.R. Teixeira, P.C. Watanabe, L.M. Maciel, F.J. de Paula, Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr. Disord. (2013). doi: 10.1186\/1472-6823-13-1","DOI":"10.1186\/1472-6823-13-1"},{"key":"1101_CR23","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jbmr.452","volume":"26","author":"MR Rubin","year":"2011","unstructured":"M.R. Rubin, D.W. Dempster, J. Sliney Jr., H. Zhou, T.L. Nickolas, E.M. Stein, E. Dworakowski, M. Dellabadia, R. Ives, D.J. McMahon, C. Zhang, S.J. Silverberg, E. Shane, S. Cremers, J.P. Bilezikian, PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J. Bone Miner. Res. 26, 2727\u20132736 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1210\/jc.2012-2984","volume":"98","author":"NE Cusano","year":"2013","unstructured":"N.E. Cusano, M.R. Rubin, D.J. McMahon, C. Zhang, R. Ives, A. Tulley, J. Sliney Jr, S.C. Cremers, J.P. Bilezikian, Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety. J. Clin. Endocrinol. Metab. 98, 137\u2013144 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1210\/jcem.84.2.5498","volume":"84","author":"Y Duan","year":"1999","unstructured":"Y. Duan, V. De Luca, E. Seeman, Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J. Clin. Endocrinol. Metab. 84, 718\u2013722 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR26","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1210\/jc.2003-030470","volume":"88","author":"Q Chen","year":"2003","unstructured":"Q. Chen, H. Kaji, M.F. Iu, R. Nomura, H. Sowa, M. Yamauchi, T. Tsukamoto, T. Sugimoto, K. Chihara, Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J. Clin. Endocrinol. Metab. 88, 4655\u20134658 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR27","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","volume":"21","author":"MR Rubin","year":"2010","unstructured":"M.R. Rubin, J. Sliney Jr., D.J. McMahon, S.J. Silverberg, J.P. Bilezikian, Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos. Int. 21, 1927\u20131934 (2010)","journal-title":"Osteoporos. Int."},{"key":"1101_CR28","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1210\/jc.2014-2267","volume":"99","author":"NE Cusano","year":"2014","unstructured":"N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, L. Anderson, E. Levy et al.. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J. Clin. Endocrinol. Metab. 99, 3694\u20133699 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"J.P. Bilezikian, A.A. Khan, J.T. Potts Jr., Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab. 94, 335\u2013339 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","volume":"78","author":"NC Harvey","year":"2015","unstructured":"N.C. Harvey, C.C. Gl\u00fcer, N. Binkley, E.V. McCloskey, M.L. Brandi, C. Cooper, D. Kendler, O. Lamy, A. Laslop, B.M. Camargos, J.Y. Reginster, R. Rizzoli, J.A. Kanis, Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78, 216\u2013224 (2015)","journal-title":"Bone"},{"key":"1101_CR31","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1210\/jc.2008-0353","volume":"93","author":"PD Miller","year":"2008","unstructured":"P.D. Miller, P.D. Delmas, R. Lindsay, N.B. Watts, M. Luckey, J. Adachi, K. Saag, S.L. Greenspan, E. Seeman, S. Boonen, S. Meeves, T.F. Lang, J.P. Bilezikian, Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J. Clin. Endocrinol. Metab. 93, 3785\u20133793 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1101_CR32","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"R.M. Neer, C.D. Arnaud, J.R. Zanchetta, R. Prince, G.A. Gaich, J.Y. Reginster, A.B. Hodsman, E.F. Eriksen, S. Ish-Shalom, H.K. Genant, O. Wang, B.H. Mitlak, Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434\u201341 (2001)","journal-title":"N. Engl. J. Med."},{"key":"1101_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/8756-3282(90)90053-2","volume":"11","author":"P Christiansen","year":"1990","unstructured":"P. Christiansen, T. Steiniche, L. Mosekilde, I. Hessov, F. Melsen, Primary hyperparathyroidism: changes in trabecular bone remodeling following surgical treatment--evaluated by histomorphometric methods. Bone 11, 75\u201379 (1990)","journal-title":"Bone"},{"issue":"Suppl 2","key":"1101_CR34","first-page":"N154","volume":"17","author":"RP Heaney","year":"2002","unstructured":"R.P. Heaney, The basis for the post-parathyroidectomy increase in bone mass. J. Bone Miner. Res. 17(Suppl 2), N154\u2013157 (2002)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bone.2012.11.041","volume":"53","author":"E Romagnoli","year":"2013","unstructured":"E. Romagnoli, C. Cipriani, I. Nofroni, C. Castro, M. Angelozzi, A. Scarpiello, J. Pepe, D. Diacinti, S. Piemonte, V. Carnevale, S. Minisola, Trabecular Bone Score (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 53, 154\u2013159 (2013)","journal-title":"Bone"},{"key":"1101_CR36","unstructured":"C. Cipriani, B.C. Silva, N. Cusano, A. Costa, D. Irani, A. Abraham, D. McMahon, L.B. Anderson, E. Levy, M. Rubin, J.P. Bilezikian, Beneficial Effects of PTH(1-84) in Hypoparathyroidism as Determined by Trabecular Bone Score (TBS) 2014 ASBMR poste # SU0015 (2014)"},{"key":"1101_CR37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"S. Hansen, E.M. Hauge, L. Rasmussen, J.E. Jensen, K. Brixen, Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J. Bone Miner. Res. 27, 1150\u20131158 (2012)","journal-title":"J. Bone Miner. Res."},{"key":"1101_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"L. Rolighed, L. Rejnmark, T. Sikjaer, L. Heickendorff, P. Vestergaard, L. Mosekilde, P. Christiansen, Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab. 99, 1072\u20131080 (2014)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1101-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:24:40Z","timestamp":1718843080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1101-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1101-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]},"assertion":[{"value":"27 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DH is co-owner of the TBS patent and has corresponding ownership shares and interest in Medimaps group. All the other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}